4 results  1 of 1 

1 Recombinant zoster vaccine (Shingrix®): a new option for the prevention of herpes zoster and postherpetic neuralgia
Grisuna Singh, Sejin Song, Eunjoo Choi, Pyung-Bok Lee, Francis Sahngun Nahm
Korean J Pain.2020;33(3):201-207.   Published online 2020 July 1     DOI: http://dx.doi.org/10.3344/kjp.2020.33.3.201
      
2 Optimal Timing of Zoster Vaccination After Shingles: A Prospective Study of the Immunogenicity and Safety of Live Zoster Vaccine
Eunyoung Lee, June Young Chun, Kyoung-Ho Song, Pyoeng Gyun Choe, Ji Hwan Bang, Eu Suk Kim, Hong Bin Kim, Sang Won Park, Nam Joong Kim, Wan Beom Park, Myoung-don Oh
Infect Chemother.2018;50(4):311-318.   Published online 2018 December 14     DOI: http://dx.doi.org/10.3947/ic.2018.50.4.311
      
3 Immunogenicity and Safety of a Live Attenuated Zoster Vaccine (ZOSTAVAX™) in Korean Adults
Won Suk Choi, Jung-Hyun Choi, Jun Yong Choi, Joong Sik Eom, Sang Il Kim, Hyunjoo Pai, Kyong Ran Peck, Jang Wook Sohn, Hee Jin Cheong
J Korean Med Sci.2016;31(1):13-17.   Published online 2015 December 24     DOI: http://dx.doi.org/10.3346/jkms.2016.31.1.13
      
4 Herpes Zoster Vaccination
Kyung Hoon Kim
Korean J Pain.2013;26(3):242-248.   Published online 2013 July 1     DOI: http://dx.doi.org/10.3344/kjp.2013.26.3.242
      

 1 of 1